S-337395
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for S-337395, covering 2024-07-10 to 2026-03-31. Get the full timeline:
Most recent: Clinical Trial Update: A Study of S-337395 in Symptomatic Nonhospitalized Adults With Respiratory Syncytial Virus (RSV) Who Are at High Risk of Progression to Severe Disease [Phase 2]